Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report
- 9 October 2015
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 35 (7) , 675-680
Abstract
Purpose We describe haploidentical hematopoietic cell transplantation (HCT) with high-dose post-transplant cyclophosphamide (PTCy) in a boy with x-linked chronic granulomatous disease (CGD). Methods A persistent and life-threatening fungal infection was the indication for HSCT. Non-myeloablative conditioning with PTCy (50 mg/kg days 3 and 4) was used in the absence of fully matched donors. Results Engraftment occurred on day 24. The patient experienced Grade 2 graft-versus-host disease of the skin and gastrointestinal tract and CMV infection, both of which were controlled. Chimerism was 100 % at days 30 and 6 months. Cessation of antifungal therapy was consistent with cure of the infection. Conclusions Haploidentical HCT with high-dose PTCy for CGD is feasible and succeeded even in the context of active infection.Keywords
This publication has 38 references indexed in Scilit:
- Chronic granulomatous disease: Overview and hematopoietic stem cell transplantationJournal of Allergy and Clinical Immunology, 2011
- The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohortTransfusion, 2010
- Periostitis Secondary to Prolonged Voriconazole Therapy in Lung Transplant RecipientsAmerican Journal of Transplantation, 2009
- Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 PatientsAntimicrobial Agents and Chemotherapy, 2008
- Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantationBlood, 2003
- Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamideTransplantation and Cellular Therapy, 2002
- Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous diseaseArchives of Disease in Childhood, 2001
- Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1999
- Alloimmunization after granulocyte transfusionsTransfusion, 1996
- Effect of HLA Compatibility on Engraftment of Bone Marrow Transplants in Patients with Leukemia or LymphomaNew England Journal of Medicine, 1989